An enhanced risk model incorporating medication use, prior healthcare utilization, and mental health with comorbid health conditions predicts healthcare utilization better than health conditions alone.
Lindsey R. Sangaralingham, MPH
Advertisement
Articles by Lindsey R. Sangaralingham, MPH
New hepatitis C medications have been quickly adopted into practice and increased treatment rate. The median out-of-pocket costs of new medications were relatively low.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5